A wheelchair user faces costly damage from street litter, while a son struggles to help aging parents prepare for the future.

Political strategist and adviser Yaron Finkelstein claims there’s “a lot of sympathy” for Prime Minister Anthony Albanese as ...

Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...

Results from the Phase III BASIS trial show that once-weekly subcutaneous Hympavzi reduced annualized bleeding rates by 93% ...

Every woman dreams of being a mother. Or does she really? In Karlovy Vary Film Festival contender "Out of Love," two ...

President Trump said that his administration is working with Texas state and local officials in response to fatal flash ...

Pfizer's Hympavzi showed superior bleed control in hemophilia A and B patients with inhibitors, reducing bleeding rates and ...

Approved eight months ago for a certain class of patients with both hemophilia A or B, Pfizer’s Hympavzi has now shown its ...

Former NASCAR driver Ken Schrader shared his take on the job of the NASCAR race director, days after Cody Ware's Chicago crash.

Turning to the CEPEP cuts, Ghany said the Government must make tough choices and is strategically spending its “political ...

The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with ...

Pfizer said a late-stage study of its Hympavzi hemophilia drug met its key goals in patients with the blood-clotting disorder who have inhibitors that can render some treatments ineffective.